This article was originally published in Start Up
A broadly enabling technology can be almost a problem for a biomaterials start-up. The challenge is finding and exploiting the killer application.
You may also be interested in...
One of the longest awaited revolutions has been that of biologicals in orthopedics. The positive buzz around BMP-2 at this year's North American Spine Society meeting has some industry executives asking whether the revolution has arrived.
Intercytex Ltd will avoid the gap from laboratory to man with implants that get the body to do its own tissue engineering. The company's first project will be a tissue-engineered kidney.
Start-ups developing man-made surrogates for living processes hope to achieve the alchemy of turning base materials into human tissue.